All Product Recalls

Browse through 2,959 product recalls and safety alerts. Filter by hazard level, status, or search for specific products.

Health & Personal Care
HIGH
FDA DEVICE

Philips Medical Systems Nederland Faces High-Risk Recall for Allura Xper FD20/15 BIOS Battery

Philips Medical Systems Nederland B.V. recalls 300 units of the Allura Xper FD20/15 with model 722058 after the BIOS battery may deplete prematurely, causing startup failure. The recall covers worldwide distribution. Patients and healthcare providers should stop using the device immediately and follow manufacturer instructions.

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
The BIOS
Read more
Health & Personal Care
HIGH
FDA DEVICE

Philips Medical Systems Nederland Blames BIOS Battery Design Flaw in Allura Centron 722400 Recall (Z

Philips Medical Systems Nederland B.V. recalls 313 Allura Centron devices with model 722400 worldwide after a BIOS battery drains too quickly. The issue can halt the system start-up with no user warning. The recall was issued September 3, 2025 and remains active as of October 8, 2025. Consumers should contact Philips or their healthcare provider for instructions.

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
The BIOS
Read more
Health & Personal Care
HIGH
FDA DEVICE

Philips Medical Systems Recalls 87 BIOS Battery Models After Start-up Failure Risk

Philips Medical Systems recalled 87 BIOS battery systems sold worldwide due to a high risk of start-up failure. A rapid depletion of the BIOS battery may halt system operations without warning, affecting patient care. Healthcare providers should stop using the device immediately and follow the recall instructions from the manufacturer.

Philips Medical Systems Nederland B.V.
The BIOS
Read more
Health & Personal Care
HIGH
FDA DEVICE

Philips Allura Xper FD20/20 Recall 115 Units Over Startup-Battery Risk (2025)

Philips Medical Systems Nederland recall 115 Allura Xper FD20/20 imaging systems worldwide after reports that the BIOS battery may deplete prematurely. The startup process may halt with no user alert. Hospitals and providers should stop using affected units and await manufacturer instructions.

Philips Medical Systems Nederland
The BIOS
Read more
Health & Personal Care
HIGH
FDA DRUG

Viorele Desogestrel/Ethinyl Estradiol Recall 2025 for Impurities

Viorele birth-control pills are recalled in the United States for failed impurity and degradation specifications. Glenmark Pharmaceuticals Inc. is distributing the issue nationwide, affecting 26,928 packs. Patients should stop using the product and contact a clinician for guidance.

Viorele
Failed Impurities/Degradation
Read more
Health & Personal Care
HIGH
FDA DEVICE

Philips Allura Xper FD10 Recalled for BIOS Battery Startup Failure (2,317 Units Worldwide, 2025)

Philips Medical Systems Nederland recalled 2,317 Allura Xper FD10 imaging systems worldwide, including 497 in the United States. The BIOS battery may deplete faster than expected, causing the startup process to halt with no user alerts. Hospitals should stop using the devices and await manufacturer instructions.

Philips Medical Systems Nederland
The BIOS
Read more
Health & Personal Care
HIGH
FDA DEVICE

Philips Allura Xper FD10 OR Table 722033 Recall 2 Units Worldwide (2025)

Philips Medical Systems Nederland B.V. recalls 2 Allura Xper FD10 OR Tables worldwide, including the United States. The BIOS battery may deplete faster than expected, halting the start-up with no user warning. Hospitals should stop using the devices and await recall instructions by letter.

Philips Medical Systems Nederland B.V.
The BIOS
Read more
Health & Personal Care
HIGH
FDA DEVICE

Inpeco Recall: 8 FlexLab FLX Potassium Test System Units Over Unverified HIL Function (2025)

Inpeco recalled eight FlexLab FLX System Potassium Test System units sold in California and New York. The recall targets the Sample Integrity Module HIL function, which detects hemolysis, icterus and lipemia. The FDA has not evaluated this function for safety or effectiveness, risking erroneous results or delays. Labs should stop using the device immediately.

Inpeco
The FlexLab
Read more
Health & Personal Care
HIGH
FDA DEVICE

PHILIPS Allura Xper FD10/10 Recall Tied to BIOS Battery Depletion

Philips Medical Systems Nederland B.V. recalled 585 units of the Allura Xper FD10/10 diagnostic system globally, including 145 in the United States, after reports that the BIOS battery can deplete faster than expected and halt system startup. The recall covers models 722005, 722011, and 722027. Healthcare facilities should stop using the device and follow manufacturer instructions for remediation.

Philips Medical Systems Nederland B.V.
The BIOS
Read more
Health & Personal Care
HIGH
FDA DEVICE

Philips Allura Xper FD20 BiOS Battery Recall Affects 5,067 Units Worldwide

Philips Medical Systems Nederland B.V. recalls 5,067 Allura Xper FD20 imaging systems worldwide. The BIOS battery may deplete faster than planned, causing the system to fail to start. The issue affects 1,626 US and 3,441 international units. Customers should stop using affected devices and follow manufacturer instructions.

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
The BIOS
Read more
Health & Personal Care
HIGH
FDA DEVICE

Philips Recalling 298 Allura Xper FD20 OR Tables Worldwide Over BIOS Battery Risk (2025)

Philips Medical Systems Nederland B.V. recalled 298 Allura Xper FD20 OR Tables worldwide after a BIOS battery depletion risk could prevent the system from starting. The battery may run down faster than designed, halting startup with no warning. Hospitals and clinicians should stop using the devices immediately and await recall instructions by letter.

Philips
The BIOS
Read more
Health & Personal Care
HIGH
FDA DRUG

High-Risk Antibiotic Recall: Sulfamethoxazole and Trimethoprim 800/160 mg Double Strength Packets Re

A high-risk recall of sulfamethoxazole and trimethoprim 800 mg/160 mg double-strength tablets is active nationwide in the United States. The Harvard Drug Group and distribution partners have halted use of a lot due to a foreign-substance finding in packaging material. No tablets tested positive for micro-organisms. Consumers should stop using the product and consult their healthcare providers.

SULFAMETHOXAZOLE AND TRIMETHOPRIM
Presence of
Read more
Health & Personal Care
HIGH
FDA DRUG

Major Pharmaceuticals Sulfamethoxazole and Trimethoprim 800 mg/160 mg 100-Tablets Recall 2025

Major Pharmaceuticals recalls sulfamethoxazole and trimethoprim 800 mg/160 mg double-strength tablets sold nationwide. A specific lot of packaging coil used in production was found to contain a microorganism in the packaging area, though no microorganism was detected on the tablets. Consumers should stop using the product and follow guidance from Major Pharmaceuticals or their healthcare provider.

Sulfamethoxazole and Trimethoprim
Presence of
Read more
Health & Personal Care
HIGH
FDA DEVICE

LeMaitre Vascular Artegraft Collagen Vascular Grafts Recall 2025: 28 U.S. Units Affected

LeMaitre Vascular recalled 28 Artegraft Collagen Vascular Grafts distributed nationwide in 17 states. The grafts use bovine carotid arteries sourced from a supplier not reviewed by the appropriate regulatory authority. Patients and healthcare providers should stop using the device immediately and contact LeMaitre Vascular for instructions.

LeMaitre Vascular
The bovine
Read more
Health & Personal Care
HIGH
FDA DEVICE

Canon Medical System SPOT Fluoro Digital Radiography System Recall Affects 8 Units in US (2025)

Canon Medical System, USA recalls 8 SPOT Fluoro digital radiography systems in the United States after a software defect could expose patients to unintended X-ray exposure. The issue occurs when the acquisition program changes and the default ROI causes the collimator and static image to partially cover the collimated area. Stop using the affected devices and follow manufacturer instructions for a

Canon Medical System
It has
Read more
Health & Personal Care
HIGH
FDA DRUG

Fagron Compounding Services Bevacizumab Syringe Recall Affects 109,320 Units Nationwide

Fagron Compounding Services recalls 109,320 sterile single-dose bevacizumab syringes nationwide due to lack of assurance of sterility. Healthcare providers and patients should stop using the product immediately. Contact Fagron Compounding Services or a healthcare provider for guidance. The recall was issued on 2025-08-29 and remains active as of 2025-09-24.

Fagron Compounding Services
Lack of
Read more
Previous
12345...148
Next
Advertisement